Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02977468
Title Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer (Pembro/IORT)
Acronym Pembro/IORT
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Eileen Connolly
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Emory University RECRUITING Atlanta Georgia 30322 United States Details
Loyola University Chicago RECRUITING Maywood Illinois 60153 United States Details
Columbia University Irving Medical Center RECRUITING New York New York 10032 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field